AFL Approves Use Of Regeneus's (ASX:RGS) Stem Cell Therapy, Hiqcell For Injured Players

Regeneus Ltd announced today that the Australian Football League has granted caseby-case approval for the use of its innovative stem cell therapy, HiQCell as a treatment option for injured AFL players, typically including impact related osteoarthritis and tendonitis.

http://ift.tt/1qwLuxI